相关实验视频

Updated: Jul 24, 2025

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

在质母细胞瘤复发中使用Honokiol:一个病例报告

Ce Wang¹, Zehao Cai¹, Yue Huang²

¹Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

Frontiers in neurology

|July 10, 2023

概括

复发性质母细胞瘤 (GBM) 缺乏标准治疗方法. 在患有复发性GBM的患者中,在三个治疗阶段内,脂质体红基醇显示出有效和安全的反应.

科学领域:

神经瘤学神经瘤学
药理学药理学是指药理学的学科.
纳米医学是一种纳米医学.

背景情况:

质母细胞瘤 (GBM) 是一种高度攻击性的原发性脑瘤,对于复发性疾病没有确立的护理标准.
荣基醇是一种天然的原体,表现出抗癌特性,并正在研究其在GBM中的治疗潜力.
脂质体封装增强了治疗剂的输送和疗效.

关键词:

血液脑屏障的透性透性临床试验临床试验临床试验临床试验临床试验质母细胞瘤是什么这是一种脂质体的Honokiol.瘤进展的进展情况

更多相关视频

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...